194 • Alternatives to Animal Use in Research, Testing, and Education 
tives to theDraizeEye Test: Alternative Methodism 
Toxicology, Vol. 3, A. Goldberg (ed.) (New York: 
Mary Ann Liebert, Inc., 1985). 
68. Miletich, D.J., Khan, A., Albrecht, R.F., et al., “Use 
of Heart Cell Cultures as a Tool for the Evaluation 
of Halothan Arrhythmia,” Toxicol. Appl. Pharmacol. 
70:181-187, 1983. 
69. Molingengo, L., "The Curve Doses v. Survival Time 
in the Evaluation of Acute Toxicity,” J. Pharm. 
Pharmacol. 31:343-344, 1979. 
70. Morrison, J.K, Quinton, R.M., and Reinert, H., “The 
Purpose and Value of LD 50 Determinations, "Mod- 
ern Trends in Toxicology, Vol. I, E. Boyland and 
R. Goulding (eds.) (London: Butterworths, 1968). 
71. Muller, H., and Kley, H.P., “Retrospective Study 
of the Reliability of an Approximate LD S0 Deter- 
mined With a Small Number of Animals,” Arch. 
Toxicol. 51:189-196, 1982. 
72. Nardone, R.M., and Bradlaw, J., “Toxicity Testing 
With In Vitro Systems: 1. Ocular Tissue Culture,” 
J. Toxicol. -Cut. Ocular Toxicol. 2:81-98, 1983. 
73. Nardone, R.M., and Ouellette, L.A., “Scope of ‘Alter- 
natives’: Overview of the State of the Art,” con- 
tract report prepared for the Office of Technol- 
ogy Assessment, U.S. Congress, July 1984. 
74. National Research Council, Models for Biomedi- 
cal Research: A New Perspective (Washington, DC: 
National Academy Press, 1985). 
75. Neal, R.A., President, Chemical Industry Institute 
of Toxicology, Research Triangle Park, NC, per- 
sonal communication, June 1985. 
76. Nelson, K.F., and Acosta, D., “Long-Term Mainte- 
nance and Induction of Cytochrome P-450 in Pri- 
mary Cultures of Rat Hepatocytes, "Biochem. Phar- 
macol. 31:2211-2214, 1982. 
77. New Scientist, “Human Placenta Can Test Drug 
Safely,” 1417:20, Aug. 16, 1984. 
78. Northup, S.J., "Perspectives on Alternative Meth- 
ods of Toxicological Testing,” J. Parenter. Sci. Tech- 
nol. 37:225-226, 1983. 
79. Northup, S.J., “Mammalian Cell Culture Models,” 
Handbook of Biomaterials Evaluation, A. Von 
Recum (ed.) (in press). 
80. Organization for Economic Cooperation and De- 
velopment, Guidelines for Testing of Chemicals, 
and addenda (Paris: 1981). 
81. Paine, A.J., Hockin, L.J, and Allen, C.M., “Long 
Term Maintenance and Induction of Cytochrome 
P-450 in Rat Liver Cell Culture,” Biochem. Pharmacol. 
31:1175-1178, 1982. 
82. Parry, J.M., Parry E.M., and Parrett, J.C., “Tumor 
Promoters Induce Mitotic Aneuploidy in Yeast,” 
Nature 294:263-265, 1981. 
83. Philips, L., Steinberg, M., Maibach, H.I., et al., “A 
Comparison of Rabbit and Human Skin Response 
to Certain Irritants,” Toxicol. Appl. Pharmacol. 
21:369-382, 1972. 
84. Pomerat, C.M., and Leake, C.D., "Short Term Cul- 
tures for Drug Assays: General Considerations,” 
Ann. N.Y. Acad. Sci. 58:1110-1128, 1954. 
85. Pott, P., Chirurgical Observations Relative to the 
Cataract, the Polypus of the Nose, the Cancer of 
the Scrotum, the Different Kinds of Ruptures, and 
the Mortification of the Toes and Feet (London: 
Hawes, Clarke, and Collins, 1775). 
86. Prasad, R., Shopsis, C., and Hochstadt, J., “Nutri- 
ent Transport in a Bovine Lens Epithelial Cell Line,” 
J. Cell Physiol. 107:231-236, 1981. 
87. Ramazzini, B., Diseases of Workers, 1700 (trans- 
lation of the Latin text of 1713 by Wilmer Cage 
Wright) (Chicago: University of Chicago Press, 
1940). 
88. Rekker, R.F.,“LD S0 Values: Are They About to Be- 
come Predictable?” TIPS 383-384, October 1980. 
89. Rose, S.L., and Jurs, P.C., “Computer Assisted 
Studies of Structure -Activity Relationships of N- 
nitroso Compounds Using Pattern Recognition,” 
J. Med. Chem. 25:769-776, 1982. 
90. Rowan, A.N., Of Mice, Models, and Men: A Criti- 
cal Evaluation of Animal Research (Albany, NY: 
State University of New York Press, 1984). 
91. Rowan, A.N., and Goldberg, A.M., “Perspectives 
on Alternative to Current Animal Testing Tech- 
niques in Preclinical Toxicology, "Ann. Rev. Phar- 
macol. Toxicol. 25:225-24 7, 1985. 
92. Sabourin, T.D., and Goss, L.B., Study of Alterna- 
tive Species for Biological Testing, final report to 
the Energy Analysis and Environment Division of 
the Electric Power Research Institute, Battelle Lab- 
oratories, Columbus, OH, 1984. 
93. Sabourin, T.D., Carlton, B.D., Faulk, R.T., et al. (Bat- 
telle Laboratories), “Animal Testing for Safety and 
Effectiveness,” contract report prepared for the 
Office of Technology Assessment, U.S. Congress, 
1985. 
94. Schultz, E., and Fuchs, H., "A New Approach to 
Minimizing the Number of Animals Used in Acute 
Toxicity Testing and Optimizing the Information 
of Test Results,” Arch. Toxicol. 51:197-220, 1982. 
95. Sharpe, R., “Four Reasons Why a Rabbit Should 
Not Be Turned Into a Guinea Pig, "Progress With- 
out Pain (Lord Dowding Fund, National Anti -Vivi- 
section Society, Ltd., London) 22: 1984. 
96. Shopsis, C., Borenfreund, E., Walberg, J., et al., 
“In Vitro Cytotoxicity Assays as Potential Alterna- 
tives to the Draize Ocular Irritancy Test," Alterna- 
tive Methods in Toxicology: Alternative Approaches, 
A.M. Goldberg (ed.) (New York: Mary Ann Leibert, 
Inc., 1984). 
97. Simpson, J.M., Sowell, Z.L., Sarley, J.T., et al., “Ef- 
